Eton Pharmaceuticals, Inc. (ETON) short interest & options flow
NASDAQEton Pharmaceuticals heads into its November earnings with short sellers rebuilding positions steadily and options sentiment cooling from its earlier bullish extreme. The short-side pressure is real but measured. Short interest has climbed 42% over the past month to 6.9% of free float, an acceleration that gathered pace this week with a further 4% rise in the seven days through…
ETON short interest fell 21.3% over one week to 4.67% of free float, while availability surged to 1,074%, signaling abundant borrow supply despite recent insider selling.
- Market cap
- $1.35B
- Next earnings
- 12 Nov 2026
Key data as of 6 Nov 2026
ETON news and analysis
RSSNo long-form analysis yet for ETON. Pulse alerts and the live data picture are available on ORTEX.
Open ETON on ORTEX →Want the live picture for ETON?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ETON — free to start on ORTEX.
Sign up for free →Open ETON on ORTEX